Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders??? Equity

v3.20.2
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
March 2019 Issuance
Lincoln Park
Common Stock
Common Stock
March 2019 Issuance
Common Stock
Lincoln Park
Additional Paid-In Capital
Additional Paid-In Capital
March 2019 Issuance
Additional Paid-In Capital
Lincoln Park
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2018       28,528,663              
Beginning balance at Dec. 31, 2018 $ 14,272     $ 29     $ 40,564     $ (26,356) $ 35
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issued for cash - sale of common stock (in shares)         5,250,000 605,367          
Issued for cash - sale of common stock   $ 3,226 $ 883   $ 5     $ 3,221 $ 883    
Stock options exercised (in shares)       25,000              
Stock options exercised 5           5        
Stock-based compensation 348           348        
Consolidated net loss (4,041)                 (4,041)  
Cumulative translation adjustment (11)                   (11)
Ending balances (in shares) at Mar. 31, 2019       34,409,030              
Ending balances at Mar. 31, 2019 14,682     $ 34     45,021     (30,397) 24
Beginning balance (in shares) at Dec. 31, 2018       28,528,663              
Beginning balance at Dec. 31, 2018 14,272     $ 29     40,564     (26,356) 35
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Consolidated net loss (5,262)                    
Ending balances (in shares) at Jun. 30, 2019       45,197,048              
Ending balances at Jun. 30, 2019 22,092     $ 45     53,643     (31,618) 22
Beginning balance (in shares) at Mar. 31, 2019       34,409,030              
Beginning balance at Mar. 31, 2019 14,682     $ 34     45,021     (30,397) 24
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issued for cash - sale of common stock (in shares)       9,375,000              
Issued for cash - sale of common stock 3,584     $ 9     3,575        
Warrants exercised (in shares)       1,413,018              
Warrants exercised 4,731     $ 2     4,729        
Stock-based compensation 318           318        
Consolidated net loss (1,221)                 (1,221)  
Cumulative translation adjustment (2)                   (2)
Ending balances (in shares) at Jun. 30, 2019       45,197,048              
Ending balances at Jun. 30, 2019 22,092     $ 45     53,643     (31,618) 22
Beginning balance (in shares) at Dec. 31, 2019       45,727,700              
Beginning balance at Dec. 31, 2019 15,571     $ 46     55,055     (39,561) 31
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issued for cash - sale of common stock (in shares)       7,500,000              
Issued for cash - sale of common stock 566     $ 7     559        
Stock-based compensation 397           397        
Consolidated net loss (1,209)                 (1,209)  
Cumulative translation adjustment (33)                   (33)
Ending balances (in shares) at Mar. 31, 2020       53,227,700              
Ending balances at Mar. 31, 2020 15,292     $ 53     56,011     (40,770) (2)
Beginning balance (in shares) at Dec. 31, 2019       45,727,700              
Beginning balance at Dec. 31, 2019 $ 15,571     $ 46     55,055     (39,561) 31
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Stock options exercised (in shares) 0                    
Consolidated net loss $ (11,321)                    
Ending balances (in shares) at Jun. 30, 2020       60,403,164              
Ending balances at Jun. 30, 2020 15,629     $ 60     66,428     (50,882) 23
Beginning balance (in shares) at Mar. 31, 2020       53,227,700              
Beginning balance at Mar. 31, 2020 15,292     $ 53     56,011     (40,770) (2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                      
Issued for cash - sale of common stock (in shares)       7,170,964              
Issued for cash - sale of common stock 10,007     $ 7     10,000        
Warrants exercised (in shares)       4,500              
Warrants exercised 9           9        
Stock-based compensation 408           408        
Consolidated net loss (10,112)                 (10,112)  
Cumulative translation adjustment 25                   25
Ending balances (in shares) at Jun. 30, 2020       60,403,164              
Ending balances at Jun. 30, 2020 $ 15,629     $ 60     $ 66,428     $ (50,882) $ 23